Navigation Links
Efficient Delivery of siRNAs to Human ,,, Primary Cells: Electroporation ,,, vs. Chemical Transfection

Dmitriy Ovcharenko (Research Associate II, Ambion, Inc.)

Gene silencing using small interfering RNAs (siRNAs) has become a powerful method for studying gene function. Human primary cells are often desired for such experiments because they are more similar to their in vivo counterparts than are immortalized cells. The use of siRNAs in human primary cells continues to accelerate applications such as target validation, gene discovery, and gene therapeutic approaches that could lead to powerful new gene-specific siRNA-based therapeutics.

Chemical transfection is the standard method for introducing siRNA into immortalized cells. Unfortunately, efficient transfer of siRNAs into primary cells by chemical transfection has so far been restricted to a few cell types only. This is illustrated in Figure 1, below. Primary cells tend to be more difficult to transfect chemically in general, which has limited their use for siRNA experiments. Here we address the use of electroporation as an alternative for efficient delivery of siRNAs into primary cell types.


Chemical Transfection: Inefficient siRNA Delivery in Primary Cells
To show that chemical transfection is only useful as an siRNA delivery method for only certain types of primary cells, an siRNA targeting GAPDH was transfected into normal human umbilical vein endothelial cells (HUVEC) and normal human epidermal keratinocytes (NHEK) using a panel of chemical transfection reagents. Cells were harvested 48 hours post transfection and analyzed for GAPDH expression using real-time RT-PCR.

In HUVEC cells, use of siPORT Amine transfection reagent (Ambion) elicited a decrease in GAPDH gene expression by more than 85%. Reduction of GAPDH gene expression by >50% was accomplished in HUVEC cells using several siRNA transfection agents from other manufacturers (Figure 1, Panel A). In contrast, none of the transfection agents were capable of delivering enough GAPDH siRNA to NHEK cells to reduce GAPDH expression by more than 35% (Figure 1, Panel B). This example was chosen to emphasize that primary cells can vary widely in their ability to be efficiently chemically transfected, even when a wide variety of transfection agents and protocols are used.

Figure 1. Reduction of GAPDH Gene Expression in HUVEC and NHEK Cells Using Various Transfection Agents. A chemically synthesized siRNA targeting GAPDH and a scrambled siRNA sequence were individually transfected into HUVEC cells (Panel A) or NHEK cells (Panel B) using various commercially available transfection agents. Manufacturer standard protocols were used for all transfections. 48 hours post-transfection, the cells were harvested and analyzed by real-time RT-PCR for both GAPDH mRNA and 18S rRNA levels. 18S rRNA levels were used to normalize the GAPDH expression data. Percent expression was calculated as a percentage of gene expression compared to the negative control siRNA. Duplicates were performed for each sample.


Electroporation
An alternative to chemical transfection-mediated nucleic acid delivery is electroporation. This method involves applying an electric field pulse to induce the formation of microscopic pores (electropores) in the cell membrane. This allows molecules, ions, and water to traverse the membrane. Under specific pulse conditions, the electropores reseal and the "electroporated" cells recover and continue to grow. A distinct advantage of electroporation is that it is not dependent on cell division, and reduction in gene expression can be detected a few hours after nucleic acid delivery. This is important when working with primary cells since most divide relatively slowly if at all.

We used electroporation (Nucleofector, Amaxa) to deliver Cy3-labeled siRNA targeting GAPDH into HUVEC cells. A HUVEC-specific protocol (Amaxa) was used. We were pleasantly surprised to find that almost every cell had taken up detectable amounts of Cy3-labeled siRNA (Figure 2). The Nucleofector was then used to electroporate HUVEC, NHEK, and normal human dermal fibroblasts neonatal (NHDF-Neo) with five different concentrations of GAPDH siRNA. Real time RT-PCR revealed a dose dependent reduction in GAPDH expression in all three cell types. Some toxicity was observed at the highest siRNA dose tested (2.66 g), but there was a complete absence of non-specific effects at 1.33 g siRNA (Figure 3). To extend these results, validated siRNAs targeting CDK2, p53, and JAK1 were individually electroporated into the same set of primary cells. All three genes were efficiently silenced (Figure 4).

Figure 2. Electroporation of HUVEC Primary Cells. A Cy3-labeled GAPDH siRNA (1.33 g) was added to HUVEC primary cells and electroporated using the HUVEC-specific protocol (Amaxa) and Nucleofector machine (Amaxa). Cells were fixed 24 hours after electroporation and stained with DAPI (blue), Cy3 fluorescence (red).

Figure 3. Reduction of GAPDH Gene Expression in HUVEC, NHEK, and NHDF-neo Human Primary Cells. Different primary cell lines were electroporated using Amaxa Nucleofector technology. Varying amounts from 66 ng to 2.66 g of siRNA targeting GAPDH or 18S rRNA were used. 24 hours post-transfection, the cells were harvested and analyzed by real-time RT-PCR for both GAPDH mRNA and 18S rRNA levels. 18S rRNA levels were used to normalize the GAPDH data. Percent gene expression was calculated as a percentage of gene expression compared with the negative control siRNA. Duplicates were performed for each sample.

Figure 4. Validated siRNAs Elicit RNAi When Electroporated into Several Cell Types. Three siRNAs (1.33 g) targeting CDK2, p53, JAK1 and a scrambled sequence were electroporated into HUVEC, NHEK, NHDF-neo human primary cell lines. 24 hours post-transfection the cells were harvested and analyzed by real-time RT-PCR for gene expression levels. 18S rRNA levels were used to normalize the CDK2, p53, JAK1 data. Percent gene expression was calculated as a percentage of gene expression compared with the negative control siRNA. Duplicates were performed for each sample.


Our results demonstrate that electroporation provides an efficient non-viral method for delivering siRNAs in at least these three types of primary cells. In contrast to chemical transfection reagents, electroporation of a GAPDH siRNA reduced GAPDH expression by greater than 90% across several primary cell types, including NHEK cells, which are only poorly transfected with several common chemical transfection agents. The application of siRNA to primary cell types, a setting where genetic manipulations have traditionally proven difficult, will be a valuable tool in studies on target validation, gene discovery, and gene therapeutic approaches.


Note that it is common to see relative variations in data when conducting tissue culture experiments. Reproducibility can be achieved by rigorously following protocols.

Cy is a trademark of Amersham Biosciences.

siPORT Amine is manufactured for Ambion by Mirus.

TaqMan is a registered trademark of Applied Biosystems.


back to top


'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Efficiently Insert Unique Restriction Sites into Plasmid Vectors
2. Efficient Cleavage of Fusion Proteins to Yield Native Amino Termini
3. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
4. Efficient Transfection of Neurospora Crassa
5. Efficient Transfection of Neurospora Crassa
6. Efficient Recovery of Ultrapure Plasmid DNA
7. Efficient and Reliable PCR Setup Using Eppendorf MasterMix
8. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
9. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
10. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
11. Efficient and Reliable Linear Amplification of cRNA
Post Your Comments:
(Date:10/25/2014)... Investor-Edge has initiated coverage on ... ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), ... Pharmaceuticals Inc. (NASDAQ: PPHM ), and StemCells ... can be accessed at: http://investor-edge.com/register . ... on a positive note as the Dow Jones Industrial ...
(Date:10/22/2014)... -- Research and Markets has announced ... Market (Product types, Application, Technology, End User and ... Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... offering. This new report titled, ... and Geography) Global Size, Industry Analysis, Trends, Opportunities, ...
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Khaimah, UAE (PRWEB) October 22, 2014 ... life science and healthcare projects, announces the addition of ... DRCOG DCH to its advisory team. Dr. Siddiqui will ... team. , A graduate of University College ... was subsequently degreed in medicine in 2001. With further ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2
... Guide, ,I. Description ,II. Product Components ... ,IV. Protocol for Extraction of DNA from Whole Blood ... Whole Blood ,VI. Quantification of Amplified Products ... Application Data , References , Contact Information ...
... ,I. Description ,II. Product Components ,III. ... Protocol for Extraction of DNA from Blood Card ... Card ,VI. Quantification of Amplified Products ,VII. ... , References , Contact Information , , ,Application ...
... , , ... , , , Mutations ... of the colon, pancreas, liver, spleen, stomach or lungs. The,CDKN2A/P16 gene is ... which point mutation is present,in patient tissue samples. Freshly frozen tumor sections ...
Cached Biology Technology:Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 2Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 3Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 4Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 5Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 6Protocol for GenomePlex Whole Genome Amplification from Blood Card 2Protocol for GenomePlex Whole Genome Amplification from Blood Card 3Protocol for GenomePlex Whole Genome Amplification from Blood Card 4Protocol for GenomePlex Whole Genome Amplification from Blood Card 5Protocol for GenomePlex Whole Genome Amplification from Blood Card 6Mutation detection for the,K- rasand P16 genes 2Mutation detection for the,K- rasand P16 genes 3Mutation detection for the,K- rasand P16 genes 4Mutation detection for the,K- rasand P16 genes 5Mutation detection for the,K- rasand P16 genes 6
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... Oregon and Washington land managers have a new synthesis ... eastside moist mixed-conifer (MMC) forests in the two states. ... Forests in Eastern Oregon and Washington: A Synthesis of ... Management, a general technical report published by the U.S. ... response to a request from managers for a synthesis ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... A tiny wasp that lays its eggs under the ... most diverse groups of insects on Earth. Now researchers ... thought. (To see an audio slide show on ... By combining ecological and genetic data with the painstaking ...
... risk during cardiac procedures. Doctors performing heart surgery also ... IAEA is helping to raise awareness of threats, through ... X-ray imaging systems. The issue of radiation protection ... of lengthy angioplasty and other cardiac interventions performed under ...
... insulin-like growth factor 1 (IGF-I) in breast cancer cells predicts ... treatment, said researchers at Baylor College of Medicine in a ... Journal of Clinical Oncology. The finding gives impetus to ... various tumors. "These findings come at a critical time," ...
Cached Biology News:Diversity among parasitic wasps is even greater than suspected 2Diversity among parasitic wasps is even greater than suspected 3Protecting those who heal 2Growth factor predicts poor outcome in breast cancer 2
6B9...
... DNA polymerase from Thermus aquaticus expressed in ... 1 tube of 250 units enzyme/tube and ... DNA), is the same enzyme as AmpliTaq ... a proprietary separation process to ensure that ...
... • Enzyme concentration - 5 units/µL ,• ... higher yields ,• Leaves an 'A' ... DNA polymerase which exhibits very high activity ... applications. To ensure the quality of the ...
... AmpliTaq DNA Polymerase is the most thoroughly ... a testimony to its overall utility and ... it ideal for PCR applications. , ... results. ,, AmpliTaq DNA Polymerase is ...
Biology Products: